In addition, transgenic rats overexpressing the human tissue kallikrein gene have reduced isoproterenol-induced cardiac hypertrophy and fibrosis, and these protective effects are abolished by icatibant (Silva et al., 2000), which is a specific antagonist of B2R. The gene discussed is BDKRB2; the disease is cardiac hypertrophy.